Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by Tunee70on Jun 09, 2015 7:45pm
349 Views
Post# 23813488

RE:RE:Looking at the numbers

RE:RE:Looking at the numbersThe suprise is in the numbers.  They grossly understated the ebitda in the Loi announcement.  The margins of the acquisition are huge.  We thought we were getting 13 million in ebitda and its 18 million.  Thats a 38% increase in ebitda before we even start to cross-sell. Incredidble anyway you measure it.  Now that product line will be available across the whole platform and will drive a large increase to the bottom line.  Thats where the suprise lies. This is huge.  Never seen a company do that before.  Only explanation is they wanted their options cheaper or actually didn't know, i don't care either way.
Bullboard Posts